Company Updates
AU$24b Litigation Funding Industry drives demand for Sequince Capital
High demand for litigation funding capital in the UK continues to drive results and investor interest in Sequince Capital’s exclusive UK High Yield Income Fund
AU$24b Litigation Funding Industry drives demand for Sequince Capital
AU$24b Litigation Funding Industry drives demand for Sequince Capital
SaaS Announces Mastercard Partnership | Reshaping Business Mobility
Don’t you hate it when somebody says “I told you so”? Last week the current tenants of that sizable, terraced townhouse at 10 Downing Street and their neighbours announced a massive reduction to the E
Positive Safety Data from Third Cohort of Phase I Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327
Highlights:
7 subjects in Cohort Three intravenously dosed; RECCE® 327 at 500mg indicating to be safe and well tolerated
Minimum recruited subjects met (7); additional three (3) at this milestone req
Fund with 8 to 20% p.a. Returns | $32M Distributions Paid To Investors
“As an industry-recognised investor advocate for over 20 years, I’ve been pro-actively working with investors to turn their income, at any level, into wealth through a range of innovative investment p
Digital Maternity Start-up targets the $8B Remote Patient Monitoring opportunity in Maternity
Among the 4 million childbirths in the United States every year, more than 20% encounter some form of complication that could have been diagnosed, managed, and possibly prevented if the pregnant mothe
World Class Medical Cannabis Growing Project in Southern Africa Has Commenced Plantation.
About Botanapharm
Botanapharm is an Australian registered company with the clear objective to establish Africa’s leading cannabis cultivation firm. The company has achieved licensing in some of the ma
ASX-Listed Elanor Group Offering | Forecast Total Return of 15% p.a | Forecast Distribution Yield of 6% p.a. | Prime Commercial Grade Offering | Carbon Neutral Certification
Established in 2009, Elanor Investors Group (“Elanor” or “Group”) is an ASX-listed (ASX:ENN) Australian real estate funds management business, managing over $2.5B of assets across Australia and NZ
Backed By Leading Investment Groups and Family Offices
